Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-02-01 @ 1:36 AM
Study NCT ID:
NCT03815357
Status:
COMPLETED
Last Update Posted:
2022-07-06
First Post:
2018-12-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'C564352', 'term': 'IRAK4 Deficiency'}, {'id': 'C564468', 'term': 'Invasive Pneumococcal Disease, Recurrent Isolated, 2'}, {'id': 'D000081207', 'term': 'Primary Immunodeficiency Diseases'}], 'ancestors': [{'id': 'D030342', 'term': 'Genetic Diseases, Inborn'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}, {'id': 'D007153', 'term': 'Immunologic Deficiency Syndromes'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 380}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2017-01-31', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2022-06', 'completionDateStruct': {'date': '2021-06-30', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2022-06-30', 'studyFirstSubmitDate': '2018-12-12', 'studyFirstSubmitQcDate': '2019-01-20', 'lastUpdatePostDateStruct': {'date': '2022-07-06', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2019-01-24', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2021-06-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'incidence of primary immunodeficiency in children who present with invasive pneumococcal disease', 'timeFrame': '3 years', 'description': 'This will be picked up upon prospective immunological testing, after identification of patients with invasive pneumococcal disease. A series of tests will be performed depending on the clinical opinion of the immunology team. Such tests may include lymphocyte subsets, complement function, serum immunoglobulin levels, memory B cells, vaccine antibody responses, etc.'}, {'measure': 'types of immunodeficiency associated with children who present with invasive pneumococcal disease', 'timeFrame': '3 years', 'description': 'This will be determined based on the testing performed by the immunologists.'}], 'secondaryOutcomes': [{'measure': 'whether increased referrals of children who present with invasive pneumococcal disease for investigation of primary immunodeficiency facilitates early detection', 'timeFrame': '3 years', 'description': 'This information will come from reviewing the case series of patients who are identified from this study. The incidence of those with primary immunodeficiency will be analysed against known background rates of diagnoses.'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['streptococcus pneumoniae', 'invasive pneumococcal disease', 'primary immunodeficiency'], 'conditions': ['Invasive Pneumococcal Disease, Recurrent Isolated, 1', 'Invasive Pneumococcal Disease, Recurrent Isolated, 2', 'Invasive Pneumococcal Disease, Protection Against', 'Primary Immunodeficiency']}, 'referencesModule': {'references': [{'pmid': '24759830', 'type': 'BACKGROUND', 'citation': 'Gaschignard J, Levy C, Chrabieh M, Boisson B, Bost-Bru C, Dauger S, Dubos F, Durand P, Gaudelus J, Gendrel D, Gras Le Guen C, Grimprel E, Guyon G, Jeudy C, Jeziorski E, Leclerc F, Leger PL, Lesage F, Lorrot M, Pellier I, Pinquier D, de Pontual L, Sachs P, Thomas C, Tissieres P, Valla FV, Desprez P, Fremeaux-Bacchi V, Varon E, Bossuyt X, Cohen R, Abel L, Casanova JL, Puel A, Picard C. Invasive pneumococcal disease in children can reveal a primary immunodeficiency. Clin Infect Dis. 2014 Jul 15;59(2):244-51. doi: 10.1093/cid/ciu274. Epub 2014 Apr 23.'}, {'pmid': '14612669', 'type': 'BACKGROUND', 'citation': 'Picard C, Puel A, Bustamante J, Ku CL, Casanova JL. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):451-9. doi: 10.1097/00130832-200312000-00006.'}, {'pmid': '25738983', 'type': 'BACKGROUND', 'citation': 'Alsina L, Basteiro MG, de Paz HD, Inigo M, de Sevilla MF, Trivino M, Juan M, Munoz-Almagro C. Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics. PLoS One. 2015 Mar 4;10(3):e0118848. doi: 10.1371/journal.pone.0118848. eCollection 2015.'}]}, 'descriptionModule': {'briefSummary': 'This is a multicentre prospective audit to determine the incidence of immunodeficiency in children with IPD.\n\nAims and/or research question of the project\n\n1. To determine the incidence of primary immunodeficiency in children \\>2 years who present with IPD\n2. To determine the types of immunodeficiency associated with IPD in children'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT'], 'maximumAge': '18 Years', 'minimumAge': '0 Months', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Children presenting with invasive pneumococcal disease at any of the participating sites listed.\n\nInvasive pneumococcal disease is defined by isolation by culture or PCR of Streptococcus pneumoniae from sterile sites including blood, cerebrospinal fluid (CSF), joint fluid or pleural fluid. In those patients with bacteraemia, their presentation needs to be accompanied by signs of sepsis.', 'healthyVolunteers': True, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Children aged 0 to 18 years admitted to one of the six centres with IPD.\n\nExclusion Criteria:\n\n* Children who do not fulfil the age criteria for immunological evaluation at that particular site e.g. aged \\<2 years at Royal Children's Hospital.\n* Children with a known underlying condition predisposing to IPD i.e. nephrotic syndrome."}, 'identificationModule': {'nctId': 'NCT03815357', 'briefTitle': 'What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?', 'organization': {'class': 'OTHER', 'fullName': 'Murdoch Childrens Research Institute'}, 'officialTitle': 'What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)? A Prospective Cohort Study.', 'orgStudyIdInfo': {'id': '35266C'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Children with IPD', 'description': 'Children with IPD will be referred for immunological evaluation. The protocol for immune work up will be the same but between centres there is variation in the age criteria for referral i.e. \\>2 years in some, \\>6 months in others.', 'interventionNames': ['Other: Referral to Immunology']}], 'interventions': [{'name': 'Referral to Immunology', 'type': 'OTHER', 'description': 'Screening for primary immunodeficiency including splenic dysfunction', 'armGroupLabels': ['Children with IPD']}]}, 'contactsLocationsModule': {'locations': [{'zip': '2031', 'city': 'Sydney', 'state': 'New South Wales', 'country': 'Australia', 'facility': "Sydney Children's Hospital", 'geoPoint': {'lat': -33.86785, 'lon': 151.20732}}, {'city': 'Adelaide', 'state': 'South Australia', 'country': 'Australia', 'facility': "Adelaide Women's and Children's Hospital", 'geoPoint': {'lat': -34.92866, 'lon': 138.59863}}, {'city': 'Clayton', 'state': 'Victoria', 'country': 'Australia', 'facility': 'Monash Health', 'geoPoint': {'lat': -37.91667, 'lon': 145.11667}}, {'zip': '3049', 'city': 'Melbourne', 'state': 'Victoria', 'country': 'Australia', 'facility': "Royal Children's Hospital", 'geoPoint': {'lat': -37.814, 'lon': 144.96332}}, {'city': 'Brisbane', 'country': 'Australia', 'facility': "Lady Cilento Children's Hospital", 'geoPoint': {'lat': -27.46794, 'lon': 153.02809}}, {'city': 'Wellington', 'country': 'New Zealand', 'facility': 'Capital and Coast District Health Board', 'geoPoint': {'lat': -41.28664, 'lon': 174.77557}}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Murdoch Childrens Research Institute', 'class': 'OTHER'}, 'collaborators': [{'name': "Royal Children's Hospital", 'class': 'OTHER'}], 'responsibleParty': {'type': 'SPONSOR'}}}}